Beacon Pointe Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.18M	Buy	36,666 +10,045	+38%	+$879K	0.02%	606
2025 Q4	$2.26M	Buy	26,621 +8,921	+50%	+$712K	0.02%	570
2025 Q3	$1.28M	Sell	17,700 -2,285	-11%	-$158K	0.01%	675
2025 Q2	$1.31M	Buy	19,985 +100	+0.5%	+$6.51K	0.01%	587
2025 Q1	$1.4M	Sell	19,885 -600	-3%	-$41.7K	0.02%	551
2024 Q4	$1.35M	Buy	20,485 +409	+2%	+$28.1K	0.01%	566
2024 Q3	$1.42M	Buy	20,076 +410	+2%	+$28.6K	0.02%	545
2024 Q2	$1.3M	Buy	19,666 +1,180	+6%	+$77.3K	0.02%	574
2024 Q1	$1.26M	Hold	18,486	–	–	0.01%	623
2023 Q4	$1.14M	Sell	18,486 -1,953	-10%	-$115K	0.01%	625
2023 Q3	$1.21M	Buy	20,439 +1,395	+7%	+$85.6K	0.02%	575
2023 Q2	$1.14M	Sell	19,044 -210	-1%	-$12.5K	0.02%	501
2023 Q1	$1.12M	Sell	19,254 -150	-0.8%	-$9.04K	0.02%	517
2022 Q4	$1.2M	Buy	19,404 +600	+3%	+$36.1K	0.02%	468
2022 Q3	$1.06M	Sell	18,804 -150	-0.8%	-$9.24K	0.02%	451
2022 Q2	$1.22M	Sell	18,954 -96	-0.5%	-$6.09K	0.03%	422
2022 Q1	$1.23M	Buy	19,050 +270	+1%	+$17.1K	0.02%	562
2021 Q4	$1.25M	Sell	18,780 -357	-2%	-$22.6K	0.03%	334
2021 Q3	$1.17M	Buy	19,137 +3,126	+20%	+$199K	0.03%	384
2021 Q2	$991K	Buy	+16,011	New	+$974K	0.04%	339